Literature DB >> 24916377

Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical-metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy.

Giulia Maria Camerino1, Maria Cannone1, Arcangela Giustino2, Ada Maria Massari1, Roberta Francesca Capogrosso1, Anna Cozzoli1, Annamaria De Luca3.   

Abstract

Weakness and fatigability are typical features of Duchenne muscular dystrophy patients and are aggravated in dystrophic mdx mice by chronic treadmill exercise. Mechanical activity modulates gene expression and muscle plasticity. Here, we investigated the outcome of 4 (T4, 8 weeks of age) and 12 (T12, 16 weeks of age) weeks of either exercise or cage-based activity on a large set of genes in the gastrocnemius muscle of mdx and wild-type (WT) mice using quantitative real-time PCR. Basal expression of the exercise-sensitive genes peroxisome-proliferator receptor γ coactivator 1α (Pgc-1α) and Sirtuin1 (Sirt1) was higher in mdx versus WT mice at both ages. Exercise increased Pgc-1α expression in WT mice; Pgc-1α was downregulated by T12 exercise in mdx muscles, along with Sirt1, Pparγ and the autophagy marker Bnip3. Sixteen weeks old mdx mice showed a basal overexpression of the slow Mhc1 isoform and Serca2; T12 exercise fully contrasted this basal adaptation as well as the high expression of follistatin and myogenin. Conversely, T12 exercise was ineffective in WT mice. Damage-related genes such as gp91-phox (NADPH-oxidase2), Tgfβ, Tnfα and c-Src tyrosine kinase were overexpressed in mdx muscles and not affected by exercise. Likewise, the anti-inflammatory adiponectin was lower in T12-exercised mdx muscles. Chronic exercise with minor adaptive effects in WT muscles leads to maladaptation in mdx muscles with a disequilibrium between protective and damaging signals. Increased understanding of the pathways involved in the altered mechanical-metabolic coupling may help guide appropriate physical therapies while better addressing pharmacological interventions in translational research.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2014        PMID: 24916377     DOI: 10.1093/hmg/ddu287

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  26 in total

1.  Comparative study of calcium and calcium-related enzymes with differentiation markers in different ages and muscle types in mdx mice.

Authors:  Rhayanna B Gaglianone; Flavia Fonseca Bloise; Tania Maria Ortiga-Carvalho; Thereza Quirico-Santos; Manoel Luis Costa; Claudia Mermelstein
Journal:  Histol Histopathol       Date:  2019-07-05       Impact factor: 2.303

2.  Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase.

Authors:  Anna Cozzoli; Antonella Liantonio; Elena Conte; Maria Cannone; Ada Maria Massari; Arcangela Giustino; Antonia Scaramuzzi; Sabata Pierno; Paola Mantuano; Roberta Francesca Capogrosso; Giulia Maria Camerino; Annamaria De Luca
Journal:  Am J Physiol Cell Physiol       Date:  2014-07-30       Impact factor: 4.249

3.  Effects of Nandrolone in the Counteraction of Skeletal Muscle Atrophy in a Mouse Model of Muscle Disuse: Molecular Biology and Functional Evaluation.

Authors:  Giulia Maria Camerino; Jean-François Desaphy; Michela De Bellis; Roberta Francesca Capogrosso; Anna Cozzoli; Maria Maddalena Dinardo; Roberta Caloiero; Kejla Musaraj; Adriano Fonzino; Elena Conte; Catherine Jagerschmidt; Florence Namour; Antonella Liantonio; Annamaria De Luca; Diana Conte Camerino; Sabata Pierno
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

4.  Long-Term Quercetin Dietary Enrichment Partially Protects Dystrophic Skeletal Muscle.

Authors:  Hannah R Spaulding; Christopher G Ballmann; John C Quindry; Joshua T Selsby
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

5.  Comparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients.

Authors:  Janek Hyzewicz; Urs T Ruegg; Shin'ichi Takeda
Journal:  J Neuromuscul Dis       Date:  2015-11-22

6.  Natural disease history of mouse models for limb girdle muscular dystrophy types 2D and 2F.

Authors:  S Pasteuning-Vuhman; K Putker; C L Tanganyika-de Winter; J W Boertje-van der Meulen; L van Vliet; M Overzier; J J Plomp; A Aartsma-Rus; M van Putten
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

7.  Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia.

Authors:  Elena Conte; Giulia Maria Camerino; Antonietta Mele; Michela De Bellis; Sabata Pierno; Francesco Rana; Adriano Fonzino; Roberta Caloiero; Laura Rizzi; Elena Bresciani; Khoubaib Ben Haj Salah; Jean-Alain Fehrentz; Jean Martinez; Arcangela Giustino; Maria Addolorata Mariggiò; Mauro Coluccia; Domenico Tricarico; Marcello Diego Lograno; Annamaria De Luca; Antonio Torsello; Diana Conte; Antonella Liantonio
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-03-10       Impact factor: 12.910

8.  Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.

Authors:  Roberta Francesca Capogrosso; Paola Mantuano; Kitipong Uaesoontrachoon; Anna Cozzoli; Arcangela Giustino; Todd Dow; Sadish Srinivassane; Marina Filipovic; Christina Bell; Jack Vandermeulen; Ada Maria Massari; Michela De Bellis; Elena Conte; Sabata Pierno; Giulia Maria Camerino; Antonella Liantonio; Kanneboyina Nagaraju; Annamaria De Luca
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.834

9.  Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study.

Authors:  Giulia M Camerino; Olimpia Musumeci; Elena Conte; Kejla Musaraj; Adriano Fonzino; Emanuele Barca; Marco Marino; Carmelo Rodolico; Domenico Tricarico; Claudia Camerino; Maria R Carratù; Jean-François Desaphy; Annamaria De Luca; Antonio Toscano; Sabata Pierno
Journal:  Front Pharmacol       Date:  2017-07-27       Impact factor: 5.810

10.  Dasatinib as a treatment for Duchenne muscular dystrophy.

Authors:  Leanne Lipscomb; Robert W Piggott; Tracy Emmerson; Steve J Winder
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.